Market Newsdesk

April 2, 2021 10:45 am

BLU INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc.

PR Newswire

NEW YORK, April 2, 2021 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of BELLUS Health Inc. (“BELLUS ” or the “Company”) (NASDAQ: BLU) from September 5, 2019, through July 5, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Southern District of New York alleges violations of the Securities Exchange Act of 1934.

If you purchased BELLUS securities, and/or would like to discuss your legal rights and options please visit Bellus Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

The complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose to investors that BLU-5937 had a much higher risk of failing to demonstrate efficacy for chronic cough. Accordingly, despite Merck’s successful Phase 2 study, BLU-5937 had a high risk of failing its Phase 2 study.

Before markets opened on July 6, 2020, Defendants revealed the truth about BLU-5937’s efficacy. They announced that the drug had failed a Phase 2 study of chronic cough patients for whom other treatments had not worked. Specifically, BLU-5937 was not significantly better than a placebo at reducing the frequency at which patients coughed. The Phase 2 trial showed a “clinically meaningful and highly statistically significant effect only on a subset of patients who had high cough counts (around 32 per day), so the Company was planning a Phase 2b trial focused on those patients.

On this news, indicating that BELLUS had fallen even further behind Merck in developing an FDA-approved treatment for refractory chronic cough, the Company’s stock price plummeted over 75% to close at $2.97 on July 8, 2020 on heavy trading volume.

If you wish to serve as lead plaintiff, you must move the Court no later than May 17, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased BELLUS securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/bellushealthinc-blu-shareholder-class-action-lawsuit-stock-fraud-380/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2021 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero

Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/blu-investor-filing-deadline-bernstein-liebhard-llp-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-in-a-securities-class-action-lawsuit-against-bellus-health-inc-301261256.html

SOURCE Bernstein Liebhard LLP

April 2, 2021 10:33 am

J-POWER USA Starts Development to Convert Retired Coal Facility into New Solar and Storage Facilities

PR Newswire

CHICAGO, April 2, 2021 /PRNewswire/ — J-POWER USA Development Co., Ltd. (“J-POWER USA“) and funds managed by affiliates of Fortress Investment Group, LLC (“Fortress”) have agreed to jointly pursue development of Birchwood Solar, a 50 MWac solar plant and Birchwood Storage, a 190 MWac, energy storage facility. These projects would convert Birchwood Power, a coal plant which has been in operation since November, 1996 into facilities that will generate and store clean renewable energy.

Birchwood is J-POWER USA’s 3^rd solar project in development and part of our new initiative to add renewable generation to our existing portfolio. By re-purposing a coal-fired power plant as carbon free solar and energy storage facilities, we will continue to deliver reliable electricity generation to the marketplace. This project benefits from existing transmission infrastructure, which will be used for the new solar and storage generation. This will also enable us to continue our long-term partnership with the local community. With the decommissioning of Birchwood Power, J-POWER USA’s only coal-fired plant, our portfolio will consist exclusively of clean, efficient and reliable natural gas and renewable energy.

J-POWER USA and its affiliate companies now have interests in operating, construction and development power generating facilities, totaling approximately 7,000 MW. “This is an exciting opportunity to take a former coal plant site and transform it into an emission free, clean energy facility,” stated Mark Condon, President and CEO of J-POWER USA. “This project is part of J-POWER USA’s plan to increase our renewable portfolio and continue our efforts to build a cleaner sustainable energy future,” Condon continued.

About Fortress Investment Group, LLC
Fortress Investment Group LLC is a leading, highly diversified global investment manager. Founded in 1998, Fortress manages $49.9 billion of assets under management as of September 30, 2020, on behalf of approximately 1,800 institutional clients and private investors worldwide across a range of credit and real estate, private equity and permanent capital investment strategies.

About J-POWER USA Development Co., Ltd
J-POWER USA is a wholly owned subsidiary of J-POWER North America Holdings Co., Ltd. which is a wholly owned subsidiary of Electric Power Development Co., Ltd. (“J-POWER”) with headquarters located in Tokyo, Japan. J-POWER USA, headquartered in the greater Chicago area, has a long-term strategy to acquire, develop, finance and operate power generation facilities in North America through its team of power professionals with a proven track record of successfully developing and acquiring power projects in the IPP sector.

J-POWER stock is listed on the Tokyo Stock Exchange. In the fiscal year ending March 2020, J-POWER had revenues of US$8.4 billion and assets of approximately US$26.0 billion. With approximately 25,000 megawatts of net ownership, J-POWER is one of the world’s largest independent generators of electricity, owning 98 power plants in Japan and 34 international IPP investments.

View original content:http://www.prnewswire.com/news-releases/j-power-usa-starts-development-to-convert-retired-coal-facility-into-new-solar-and-storage-facilities-301261161.html

SOURCE J-POWER USA Development Co., Ltd.

April 2, 2021 10:32 am

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CytoDyn Inc. (“CytoDyn” or “the Company”) (OTC: CYDY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between March 27, 2020 and March 9, 2021, inclusive (the ”Class Period”), are encouraged to contact the firm before May 17, 2021.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. CytoDyn touted Leronlimab as a treatment for COVID-19 to pump the Company’s stock price at the same time its executives sold their shares. The Company engaged in a scheme with Iliad Research and Trading L.P. amongst others in which Iliad’s principal John Fife acted as an unregistered securities dealer for CytoDyn. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about CytoDyn, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210402005181/en/

The Schall Law Firm

Brian Schall, Esq.

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo

April 2, 2021 10:26 am

VRM INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Vroom, Inc.

PR Newswire

NEW YORK, April 2, 2021 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Vroom, Inc. (“Vroom” or the “Company”) (NASDAQ: VRM) from November 11, 2020, through March 3, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Southern District of New York alleges violations of the Securities Exchange Act of 1934.

If you purchased Vroom securities, and/or would like to discuss your legal rights and options please visit Vroom Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

The complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose to investors:(1) that Vroom had not demonstrated that it was able to control and scale growth in respect to its salesforce to meet the demand for its products; (2) that, as a result, the Company was forced to discount aged inventory to move through its retail channels or liquidated in its wholesale channels; (3) that, as a result, the ecommerce gross profit per unit was reasonably likely to decline; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On March 3, 2021, after the market closed, Vroom announced its fourth quarter and full year 2020 financial results in a press release. Therein, the Company reported that fourth quarter “Ecommerce Vehicle gross profit per unit decreased 13.1% to $878, driven primarily by lower sales margins, partially offset by improvements in inbound logistics and reconditioning costs per unit.” Vroom also reported that for the fourth quarter, its “[n]et loss increased 41.9% to $60.7 million.” On this news, the Company’s stock price fell $12.29 per share, or 27.9%, to close at $31.61 per share on March 4, 2021, on unusually heavy trading volume

If you wish to serve as lead plaintiff, you must move the Court no later than May 21, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery does not require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Vroom securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/vroominc-shareholder-class-action-lawsuit-stock-fraud-383/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

Contact Information
Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/vrm-investor-filing-deadline-bernstein-liebhard-llp-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-vroom-inc-301261232.html

SOURCE Bernstein Liebhard LLP

April 2, 2021 10:21 am

RRC SHAREHOLDER DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Range Resources Corporation

NEW YORK, April 02, 2021 (GLOBE NEWSWIRE) — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Range Resources Corporation (“Range Resources” or the “Company”) (NYSE: RRC) from April 29, 2016 through February 10, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Western District of Pennsylvania alleges violations of the Securities Exchange Act of 1934.

If you purchased Range Resources securities, and/or would like to discuss your legal rights and options please visit Range Resources Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

The complaint alleges that during the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Range Resources had improperly designated the status of its wells in Pennsylvania since at least 2013; (ii) the foregoing conduct subjected the Company to a heightened risk of regulatory investigation and enforcement, as well as artificially decreased the Company’s periodically reported cost estimates to plug and abandon its wells; (iii) the Company was the subject of a DEP investigation from sometime between September 2017 to January 2021 for improperly designating the status of its wells; (iv) the DEP investigation foreseeably would and ultimately did lead to the Company incurring regulatory fines; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

On February 10, 2021, prior to the close of the trading session, the DEP issued a press release announcing the payment of a $294,000 civil penalty by Range Resources to the agency for the Company’s violations of the 2012 Oil and Gas Act. The DEP had launched an investigation of the Company after finding conflicting and inaccurate information regarding the status of a Company well in Fayette County, Pennsylvania. After subpoenaing the Company for information about its wells, DEP found that “between Tuesday, July 16, 2013, and Monday, October 11, 2017, 42 of Range Resources’ conventional wells were placed on inactive status but were never used again” and that several of the Company’s wells had not been used for “12 months at the time Range Resources submitted its applications for inactive status, even though “after 12 consecutive months of no productive, the well would be classified as abandoned and must be plugged.” The Company ultimately had to plug the wells identified by DEP as having no viable future use to remediate the issue.

On this news, Range Resources’ stock price fell $0.62 per share, or 6.08%, to close at $9.57 per share on February 11, 2020.

If you wish to serve as lead plaintiff, you must move the Court no later than May 3, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Range Resources securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/rangeresourcescorporation-rrc-shareholder-class-action-lawsuit-fraud-stock-374/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

Contact Information

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

April 2, 2021 10:21 am

MGI LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Against MoneyGram International, Inc.

NEW YORK, April 02, 2021 (GLOBE NEWSWIRE) — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of MoneyGram International, Inc. (“MoneyGram” or the “Company”) (NASDAQ: MGI) from June 3, 2019, through February 22, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934.

If you purchased MoneyGram securities, and/or would like to discuss your legal rights and options please visit MoneyGram Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

The complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose to investors: (1) XRP, the cryptocurrency that MoneyGram was utilizing as part of its Ripple partnership, was viewed as an unregistered and therefore unlawful security by the SEC; (2) in the event that the SEC decided to enforce the securities laws against Ripple, MoneyGram would be likely to lose the lucrative stream of market development fees that was critical to its financial results throughout the Class Period; and (3) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.

On February 22, 2021, MoneyGram filed its annual report on Form 10-K for the year ended December 31, 2020, disclosing to shareholders that it was “possible that MoneyGram will not resume transacting with Ripple under the commercial agreement and will be unable to receive the related market development fees in 2021 and beyond.”

On this news, MoneyGram securities fell 33.2%, from a closing price on February 19, 2021 of $10.87, to a closing price on February 23, 2021 of $7.26 per share.

If you wish to serve as lead plaintiff, you must move the Court no later than April 30, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased MoneyGram securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/moneygraminternational-mgi-shareholder-class-action-lawsuit-stock-fraud-368/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

Contact Information

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

April 2, 2021 10:03 am

57 Ameriprise Financial Advisors Named to the Forbes Top Women Wealth Advisors List

57 Ameriprise Financial Advisors Named to the Forbes Top Women Wealth Advisors List

MINNEAPOLIS–(BUSINESS WIRE)–
Ameriprise Financial Inc. (NYSE: AMP), today announced that 57 of its financial advisors were named to Forbes list of the “Top Women Wealth Advisors” in the country. Forbes recognizes the industry’s top women advisors based on several factors, which include levels of ethical standards, professionalism, success in the business and client retention. The rankings are based on data provided by thousands of the nation’s most productive women advisors.

“On behalf of Ameriprise, we congratulate these very talented advisors on their well-deserved recognition,” said Deirdre McGraw, Executive Vice President of Marketing, Communications and Community Relations at Ameriprise. “The advisors on this list run successful practices that put clients at the center of everything they do. They’re an inspiration to their colleagues, communities and the next generation of advisors.”

“It’s an honor to have a significant number of Ameriprise advisors being recognized by Forbes,” said Pat O’Connell, Executive Vice President of the Ameriprise Advisor Group & Ameriprise Financial Institutions Group. “We applaud the women on this list for their dedication to their clients, families and communities. Every day, they empower their clients to make informed decisions for their lives through financial planning, best-in-class technology and premium service.”

Ameriprise is committed to being the firm of choice for women in the financial services industry. As part of its strategy to recruit, retain, develop and engage a diverse workforce, the company sponsors the Ameriprise Women’s Empowerment (WE) Network that offers mentorship opportunities, training, education and networking events.

“We know women make exceptional financial advisors and yet they’re still underrepresented in the industry,” said Bill Williams, Executive Vice President of the Ameriprise Independent Advisors. “That’s why we’re providing more opportunities to recruit, develop and mentor women with the talent and skills to succeed in this business.”

The full list of Forbes Top Women Financial Advisors can be found at Forbes.com.

Visit forbes.com for additional information about Forbes.

About Ameriprise Financial

At Ameriprise Financial, we have been helping people feel confident about their financial future for more than 125 years. With a network of approximately 10,000 financial advisors and extensive asset management, advisory and insurance capabilities, we have the strength and expertise to serve the full range of consumer financial needs. For more information, visit ameriprise.com.

Source: Forbes, “Forbes Top Women Wealth Advisors” March 24, 2021.

This ranking was developed by SHOOK Research and is based on in-person and telephone due diligence meetings to evaluate each advisor qualitatively, a major component of a ranking algorithm that includes: client retention, industry experience, review of compliance records, firm nominations; and quantitative criteria, including: assets under management and revenue generated for their firms. Investment performance is not a criterion because client objectives and risk tolerances vary, and advisors rarely have audited performance reports. Rankings are based on the opinions of SHOOK Research, LLC and not indicative of future performance or representative of any one client’s experience. Neither Forbes nor SHOOK Research receive compensation in exchange for placement on the ranking. For more information: www.SHOOKresearch.com.

Ameriprise Financial Services, LLC. Member FINRA and SIPC.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210402005014/en/

Alison Mueller, PR Director

[email protected]

(612) 678-7183

KEYWORDS: United States North America Minnesota

INDUSTRY KEYWORDS: Human Resources Women Finance Consulting Banking Accounting Professional Services Consumer Other Professional Services

MEDIA:

Logo

April 2, 2021 10:03 am

Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Review Oncology Business on April 9, 2021

Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Review Oncology Business on April 9, 2021

NEW YORK–(BUSINESS WIRE)–
Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of a presentation and conference call with investment analysts at 10 a.m. EDT on Friday, April 9, 2021. Pfizer Oncology leadership will provide an update on the Oncology pipeline progress, specifically how the company is applying its capabilities to move quickly and utilize cutting-edge science to key programs such as LORBRENA^® (lorlatinib) in ALK-positive metastatic lung cancer, elranatamab (PF-06863135) in multiple myeloma and our next generation breast cancer portfolio.

To access the live webcast, including audio, video and presentation slides, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance.

Participants will also have an opportunity to ask questions in a live Q&A session with speakers. Those participants who would like to ask a question can dial either (833) 741-0115 in the United States and Canada or (818) 488-5731 outside of the United States and Canada. The password is “Pfizer Oncology”.

Visitors to www.pfizer.com/investors will be able to view and listen to an archived copy of the webcast following the conclusion of the event.

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Disclosure Notice:The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, post-approval clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; our efforts to respond to COVID-19, including our development of a vaccine to help prevent COVID-19 that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210402005006/en/

Media:

Pamela Eisele

+1 (212) 733-1226

[email protected]

Investor:

Bryan Dunn

+1 (212) 733-8917

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Oncology Health Other Health General Health Clinical Trials Pharmaceutical Biotechnology

MEDIA:

Logo

April 2, 2021 10:03 am

Food Lion and Its Customers Help Put Hope On Their Neighbor’s Table

More Than 2.2 Million Meals To Be Donated Through the Food Lion Feeds Orange Bag Campaign

SALISBURY, N.C., April 02, 2021 (GLOBE NEWSWIRE) — This March, Food Lion Feeds helped to provide more than 2.2 million meals*, in partnership with its customers, as part of its annual orange bag campaign.

From March 3^rd through the 23^rd, customers purchased specially marked Food Lion Feeds orange bags at each of Food Lion’s more than 1,000 stores. Each bag sold helped provide 5 meals to the stores local Feeding America® member food bank.

Additionally, customers made cash donations equating to more than 1.2 million meals, which was donated to Feeding America® to help the national hunger-relief organization meet unprecedented demand during the COVID-19 pandemic.

“At Food Lion, we care about nourishing and supporting our neighbors in need” said Jennifer Blanchard, director of community relations for Food Lion. “We are grateful to our customers who supported their local neighbors this March and helped put hope on their tables. Through the purchase of specially marked orange bags and donations made at the register, we were able to make a big impact in the local towns and cities we serve.”

Since 2014, Food Lion Feeds has donated more than 750 million meals to individuals and families and has committed to donate 1.5 billion meals by 2025. For more information on Food Lion’s commitment to end hunger in the towns and cities it serves through Food Lion Feeds, please visit www.foodlion.com/feeds.

*$1 helps provide at least 10 meals secured by Feeding America® on behalf of local member food banks.

About Food Lion

Food Lion, based in Salisbury, N.C., since 1957, has more than 1,000 stores in 10 Southeastern and Mid-Atlantic states and employs more than 77,000 associates. By leveraging its longstanding heritage of low prices and convenient locations, Food Lion is working to own the easiest full shop grocery experience in the Southeast, anchored by a strong commitment to affordability, freshness, and the communities it serves. Through Food Lion Feeds, the company has donated more than 750 million meals to individuals and families since 2014 and has committed to donate 1 billion more meals by 2025. Food Lion is a company of Ahold Delhaize USA, the U.S. division of Zaandam-based Ahold Delhaize. For more information, visit www.foodlion.com or job applicants may visit www.foodlion.com/careers.

Contact:

Food Lion Media Relations
704-245-3317
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/20d91ba2-c927-4dfb-8b5e-556107225b08

April 2, 2021 10:03 am

BOK Financial Announces Date of First Quarter 2021 Earnings Conference Call

TULSA, Okla., April 02, 2021 (GLOBE NEWSWIRE) — BOK Financial Corporation (NASDAQ: BOKF) announces that financial results for the first quarter of 2021 will be released before the market open on Wednesday, April 21, 2021. The company will hold a conference call at 9 a.m. central time that morning to discuss the financial results with investors.

The live audio webcast and presentation slides will be available on the company’s investor relations website. The conference call can also be accessed by dialing 1-201-689-8471. A webcast replay will be available shortly after the live call’s conclusion on the company’s investor relations website or by dialing 1-412-317-6671 and referencing replay PIN 13718312.

About BOK Financial Corporation

BOK Financial Corporation is a more than $40 billion regional financial services company headquartered in Tulsa, Oklahoma with more than $90 billion in assets under management and administration. The company’s stock is publicly traded on NASDAQ under the Global Select market listings (BOKF). BOK Financial Corporation’s holdings include BOKF, NA; BOK Financial Securities, Inc., BOK Financial Private Wealth, and BOK Financial Insurance, Inc. BOKF, NA operates TransFund, Cavanal Hill Investment Management and BOK Financial Asset Management, Inc. BOKF, NA operates banking divisions across eight states as: Bank of Albuquerque; Bank of Oklahoma; Bank of Texas and BOK Financial (in Arizona, Arkansas, Colorado, Kansas and Missouri); as well as having limited purpose offices Nebraska, Milwaukee and Connecticut. Through its subsidiaries, BOK Financial Corporation provides commercial and consumer banking, brokerage trading, investment, trust and insurance services, mortgage origination and servicing, and an electronic funds transfer network. For more information, visit www.bokf.com.

Contact:

Cody McAlester
Vice President, Public and Investor Relations
918-595-3030